← Leaderboards
Sudarshan Rajan Iyer
Oregon Health & Science University
$241,607
Attributed
$241,607
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2020–24$100K$75K$50K$25K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$241,607 · 1
By mechanism
F30$241,607 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Gail Mandel$12,042,469
- Hui Wu$19,750,423
- Monika A Davare$1,467,915
- Robert Langland Eil$1,224,020
- Xiangshu Xiao$6,932,744
Others in their field
Other Emerging Leaders on “Drug Design”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- John Damon Chodera · Sloan-Kettering Inst Can Research$53,982,083
- Yunda Huang · Fred Hutchinson Cancer Center$52,681,952
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Drug DesignAttentionDown-RegulationBindingBiological ModelsBypassAppearanceAffinityCancer PatientCell FusionCell LineCellsCell SurvivalCell TransformationCancer CellClinical ImplementationCombatCancer GenomeCrizotinibC-TerminalDeaminaseDesignDifferential ExpressionDrug Resistance
Grant awards (5)
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies$35,605
F30 · FY2024 · CA · contact PI
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies$52,694
F30 · FY2023 · CA · contact PI
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies$51,752
F30 · FY2022 · CA · contact PI
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies$51,036
F30 · FY2021 · CA · contact PI
Resistance Mechanisms in ROS1-Fusion-Driven Malignancies$50,520
F30 · FY2020 · CA · contact PI